New drug combo aims to stop kidney rejection in its tracks
NCT ID NCT06918990
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 27 times
Summary
This study tests whether adding two drugs, carfilzomib and belatacept, to standard care can safely improve kidney function in transplant patients whose bodies are making antibodies that attack the new kidney. About 25 adults who had a kidney transplant at least 6 months ago will receive the drugs plus usual anti-rejection medicine. The goal is to reduce harmful antibodies and inflammation, helping the kidney work better.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANT REJECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cleveland Clinic
Cleveland, Ohio, 44195, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Duke University
Durham, North Carolina, 27710, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Mayo Clinic Arizona
Phoenix, Arizona, 85054, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
NYU Langone Health
New York, New York, 10016, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Northwestern University, Feinberg School of Medicine
Chicago, Illinois, 60611, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Alabama Medical Center
Birmingham, Alabama, 35294, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Cincinnati
Cincinnati, Ohio, 45267, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Wisconsin - Madison
Madison, Wisconsin, 53726, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Washington University
St Louis, Missouri, 63110, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.